Z-1822-2025 Class II Ongoing
FDA device recall Z-1822-2025 was initiated by Siemens Healthcare Diagnostics, Inc. on Apr 15, 2025 and is designated Class II. Reason for recall: Certain lots of Atellica IM Homocysteine Calibrator and ADVIA Centaur HCY Calibrator do not meet the assay Instructions for Use (IFU) reference interval due to calibrator instability resulting in… The recall status is ongoing. Affected quantity: 1,072 packs (2,144 units) - 156 packs US, 916 packs OUS.
Recall details
- Product Type
- Devices
- Report Date
- Jun 4, 2025
- Initiation Date
- Apr 15, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,072 packs (2,144 units) - 156 packs US, 916 packs OUS
Product description
Reason for recall
Distribution pattern
Worldwide - US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, FL, GA, IA, IL, IN, KY, MA, MD, ME, MI, MO, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, TX, UT, VA, VT, WI, WY and the countries of Austria, Belgium, Croatia, Curacao,¿St¿Eus, Czech¿Republic, Denmark, Egypt, Finland, France, Georgia, Germany, Greece, Hungary, Iran, Ireland, Israel, Italy, Jordan, Kuwait, Latvia, Lithuania, Nepal, Netherlands, Norway, Pakistan, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland, Turkey, Turkmenistan, U.A.E., United¿Kingdom, Vatikan City, Zaire.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1822-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026